App-supported stabilization of the success of pain day care treatment

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00022255

Enrollment

168

Registered

2020-06-22

Start date

2020-07-03

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F45.41

Interventions

Group 1: Group 1 (n=112): E-Health support via the "PainCoach" app PainCoach is an app developed in cooperation with the Finnish company BuddyHealthcare Ltd Oy for patients of the Day Pain Clinic (STK

and (c) to physiotherapeutic exercises at different levels of difficulty, which have already been learned in the STK and which will now be continued. Duration of intervention: The app is available to

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: - Participation in an information event on treatment in the Day Clinic for Pain - Participation in a pre-assessment by medicine, psychology and physiotherapy to assess suitability for day-care pain treatment - Criteria for inclusion in OPS 8-918 are met - Men and women over 18 years - Consent to participate in the examination and consent to enter the data in the pain register of the day clinic for pain

Exclusion criteria

Exclusion criteria: - Lack of consent to participate - Lack of command of the German language

Design outcomes

Primary

Measure	Time frame
The primary target value at measurement time t2 (6 months after the end of treatment) is the pain-related impairment. A confirmatory test is performed for this target value. The pain-related impairment is calculated as the mean value of the three NRS scales for impairment in everyday life, leisure time and work ability. The scales are 11-step and range from 0 (no impairment) to 10 (complete impairment). The calculation of an overall value is justified because the three items result in a subtest with sufficient reliability (evaluation of the current pain register of the STK: Internal Consistency (Cronbach's Alpha) for t0: rtt=0.89, for t2: rtt=0.93).	—

Measure

Time frame

The primary target value at measurement time t2 (6 months after the end of treatment) is the pain-related impairment. A confirmatory test is performed for this target value. The pain-related impairment is calculated as the mean value of the three NRS scales for impairment in everyday life, leisure time and work ability. The scales are 11-step and range from 0 (no impairment) to 10 (complete impairment). The calculation of an overall value is justified because the three items result in a subtest with sufficient reliability (evaluation of the current pain register of the STK: Internal Consistency (Cronbach's Alpha) for t0: rtt=0.89, for t2: rtt=0.93).

—

Secondary

Measure	Time frame
Secondary efficacy parameters Secondary target variables are evaluated for a broad coverage of potential effects of e-health support (App). Secondary efficacy parameters are at measurement time t2 (6 months after end of treatment): - Pain intensity (measured with NRS) - Anxiety, depression, stress (raised with DASS) - Health-related quality of life (surveyed with the VR-12) - physical restrictions (collected with the PSFS).	—

Measure

Time frame

Secondary efficacy parameters Secondary target variables are evaluated for a broad coverage of potential effects of e-health support (App). Secondary efficacy parameters are at measurement time t2 (6 months after end of treatment): - Pain intensity (measured with NRS) - Anxiety, depression, stress (raised with DASS) - Health-related quality of life (surveyed with the VR-12) - physical restrictions (collected with the PSFS).

—

Countries

Germany

Contacts

Public ContactMichael Hüppe

Universität zu Lübeck, Klinik für Anästhesiologie und Intensivmedizin

michael.hueppe@uni-luebeck.de0451 50040770

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026